KR100980898B1 - 마이코박테리아 유래 면역기능 증진, 면역질환 치료, 아토피성 피부질환 및/또는 면역세포 생존용 올리고뉴크레오타이드 - Google Patents
마이코박테리아 유래 면역기능 증진, 면역질환 치료, 아토피성 피부질환 및/또는 면역세포 생존용 올리고뉴크레오타이드 Download PDFInfo
- Publication number
- KR100980898B1 KR100980898B1 KR1020097017958A KR20097017958A KR100980898B1 KR 100980898 B1 KR100980898 B1 KR 100980898B1 KR 1020097017958 A KR1020097017958 A KR 1020097017958A KR 20097017958 A KR20097017958 A KR 20097017958A KR 100980898 B1 KR100980898 B1 KR 100980898B1
- Authority
- KR
- South Korea
- Prior art keywords
- immune
- cells
- odn4
- odn
- present
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (5)
- 다음 서열: 5'-AGCAGCGTTCGTGTGCGCCT-3' (서열번호 4), 5'-GTATTCGTTCGTGTCGTCCT-3' (서열번호 7) 또는 5'-TGACTCGTTCGTGTCGCATG-3' (서열번호 8)로 표시되는 면역반응 증강제(adjuvant) 또는 면역질환 치료용 올리고데옥시뉴클레오티드.
- 제1항에 있어서, 상기의 올리고데옥시뉴클레오티드는 방사선 치료시 정상 면역세포를 생존 시키는 것을 특징으로 하는 올리고데옥시뉴클레오티드.
- 제1항에 있어서, 상기의 올리고데옥시뉴클레오티드는 피부질환을 치료 또는 예방하는 것을 특징으로 하는 올리고데옥시뉴클레오티드.
- 제1항에 있어서, 상기의 올리고데옥시뉴클레오티드는 다양한 Th1/Th2 면역반응의 균형을 유지하는 것을 특징으로 하는 올리고데옥시뉴클레오티드.
- 제1항에 있어서, 상기의 올리고데옥시뉴클레오티드는 상기의 뉴크레오타이드 간의 결합이 포스포다이에스터 결합 또는 포스포로싸이오에이트 결합인 것을 특징으로 하는 올리고데옥시뉴클레오티드.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2005/000266 WO2006080596A1 (en) | 2005-01-28 | 2005-01-28 | Oligonucleotides derived from mycobacterium for stimulating immune function, treating immune-related diseases, atopic dermatitis and/or protecting normal immune cell |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020077008849A Division KR100924085B1 (ko) | 2007-04-18 | 2007-04-18 | 마이코박테리아 유래 면역기능 증진, 면역질환 치료,아토피성 피부질환 및/또는 면역세포 생존용올리고뉴크레오타이드 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090096560A KR20090096560A (ko) | 2009-09-10 |
KR100980898B1 true KR100980898B1 (ko) | 2010-09-07 |
Family
ID=36740598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020097017958A KR100980898B1 (ko) | 2005-01-28 | 2005-01-28 | 마이코박테리아 유래 면역기능 증진, 면역질환 치료, 아토피성 피부질환 및/또는 면역세포 생존용 올리고뉴크레오타이드 |
Country Status (7)
Country | Link |
---|---|
US (1) | US7902161B2 (ko) |
EP (1) | EP1841777B1 (ko) |
JP (1) | JP4836145B2 (ko) |
KR (1) | KR100980898B1 (ko) |
CN (1) | CN100485034C (ko) |
CA (1) | CA2549423C (ko) |
WO (1) | WO2006080596A1 (ko) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0923225A2 (pt) | 2008-12-02 | 2016-10-04 | Chiralgen Ltd | metodo para sintese de acidos nucleicos modificados no atomo de fosforo |
KR101360432B1 (ko) * | 2009-06-18 | 2014-02-25 | 한림대학교 산학협력단 | 리포좀에 포집된 올리고뉴클레오타이드를 유효성분으로 하는 면역증강 조성물 |
KR101885383B1 (ko) | 2009-07-06 | 2018-08-03 | 웨이브 라이프 사이언시스 리미티드 | 신규한 핵산 프로드러그 및 그의 사용 방법 |
CN103977394B (zh) | 2009-07-17 | 2016-03-09 | 翰林大学校产学协力团 | 包含脂质体包胶的寡核苷酸和表位的免疫刺激性组合物 |
JP5868324B2 (ja) | 2010-09-24 | 2016-02-24 | 株式会社Wave Life Sciences Japan | 不斉補助基 |
CN103796657B (zh) | 2011-07-19 | 2017-07-11 | 波涛生命科学有限公司 | 合成官能化核酸的方法 |
SG11201500239VA (en) | 2012-07-13 | 2015-03-30 | Wave Life Sciences Japan | Asymmetric auxiliary group |
EP4219516A3 (en) | 2012-07-13 | 2024-01-10 | Wave Life Sciences Ltd. | Chiral control |
EP2873674B1 (en) * | 2012-07-13 | 2020-05-06 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant |
EP2892353A4 (en) * | 2012-09-10 | 2016-10-26 | Yeda Res & Dev | INDIVIDUALIZED IMMUNOMODULATION THERAPY FOR NEURODEGENERATIVE ILLNESSES, CNS LESIONS AND AGGREGATIVE DEMENTIA |
WO2015108047A1 (ja) * | 2014-01-15 | 2015-07-23 | 株式会社新日本科学 | 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤 |
JPWO2015108048A1 (ja) * | 2014-01-15 | 2017-03-23 | 株式会社新日本科学 | 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤 |
US10322173B2 (en) | 2014-01-15 | 2019-06-18 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent |
KR102423317B1 (ko) | 2014-01-16 | 2022-07-22 | 웨이브 라이프 사이언시스 리미티드 | 키랄 디자인 |
CN105012333B (zh) * | 2015-07-23 | 2019-03-26 | 华南农业大学 | 一种高效抗炎性pb odn序列及其应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6207646B1 (en) * | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
WO1998040100A1 (en) * | 1997-03-10 | 1998-09-17 | Ottawa Civic Loeb Research Institute | USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT |
US6406705B1 (en) * | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
CA2419894A1 (en) * | 2000-09-15 | 2002-03-21 | Coley Pharmaceutical Gmbh | Process for high throughput screening of cpg-based immuno-agonist/antagonist |
US20040029129A1 (en) * | 2001-10-25 | 2004-02-12 | Liangsu Wang | Identification of essential genes in microorganisms |
KR100456681B1 (ko) * | 2002-05-22 | 2004-11-10 | 주식회사 대웅 | 박테리아의 염색체 dna 파쇄물과 비독성리포폴리사카라이드를 포함하는 면역강화 및 조절 조성물 |
SG2011035342A (en) * | 2002-12-23 | 2016-12-29 | Dynavax Tech Corp | Immunostimulatory sequence oligonucleotides and methods of using the same |
-
2005
- 2005-01-28 KR KR1020097017958A patent/KR100980898B1/ko active IP Right Grant
- 2005-01-28 CA CA2549423A patent/CA2549423C/en not_active Expired - Fee Related
- 2005-01-28 JP JP2007526969A patent/JP4836145B2/ja not_active Expired - Fee Related
- 2005-01-28 US US10/581,656 patent/US7902161B2/en not_active Expired - Fee Related
- 2005-01-28 WO PCT/KR2005/000266 patent/WO2006080596A1/en active Application Filing
- 2005-01-28 CN CNB2005800064479A patent/CN100485034C/zh not_active Expired - Fee Related
- 2005-01-28 EP EP05710840.9A patent/EP1841777B1/en not_active Not-in-force
Non-Patent Citations (2)
Title |
---|
Annu. Rev. Immunol. Vol.20, 709-760 (2002) |
Nature, Vol.374, 546-549 (1995) |
Also Published As
Publication number | Publication date |
---|---|
JP4836145B2 (ja) | 2011-12-14 |
CN1926145A (zh) | 2007-03-07 |
KR20090096560A (ko) | 2009-09-10 |
EP1841777B1 (en) | 2015-09-30 |
US20080249291A1 (en) | 2008-10-09 |
US7902161B2 (en) | 2011-03-08 |
EP1841777A4 (en) | 2008-10-29 |
WO2006080596A1 (en) | 2006-08-03 |
CN100485034C (zh) | 2009-05-06 |
CA2549423C (en) | 2012-10-02 |
EP1841777A1 (en) | 2007-10-10 |
JP2008501787A (ja) | 2008-01-24 |
CA2549423A1 (en) | 2006-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100980898B1 (ko) | 마이코박테리아 유래 면역기능 증진, 면역질환 치료, 아토피성 피부질환 및/또는 면역세포 생존용 올리고뉴크레오타이드 | |
EP1807094B1 (en) | Therapeutic use of cpg oligodeoxynucleotide for skin disease | |
US7935675B1 (en) | Immunostimulatory nucleic acid molecules | |
EP2360252B1 (en) | Immunostimulatory nucleic acid molecules comprising GTCGTT motifs | |
US8008266B2 (en) | Methods of treating cancer using immunostimulatory oligonucleotides | |
JP2003144184A (ja) | 免疫調節オリゴヌクレオチド | |
EA008777B1 (ru) | Способы и продукты, относящиеся к лечению и предупреждению инфекции вируса гепатита c | |
US7354907B2 (en) | Short immunomodulatory oligonucleotides | |
KR100924085B1 (ko) | 마이코박테리아 유래 면역기능 증진, 면역질환 치료,아토피성 피부질환 및/또는 면역세포 생존용올리고뉴크레오타이드 | |
KR100906970B1 (ko) | 피부 면역질환에 대한 CpG 올리고데옥시뉴클레오티드의치료학적 용도 | |
AU2005297758B2 (en) | Oligonucleotides derived from Mycobacterium for stimulating immune function, treating immune-related diseases, atopic dermatitis and/or protecting normal immune cell |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130829 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20140829 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20150826 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20170901 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20180830 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20190826 Year of fee payment: 10 |